Penny McCormick

Penny McCormick

Chief Executive Officer

  • > Penny is a skilled commercial professional with several years' leadership experience in the consumer women’s health medical device market. Prior to joining MyHealthChecked, Penny was Managing Director of BBI Healthcare, an £11.5m consumer healthcare business providing a branded healthcare portfolio into UK high street and multiple grocery retailers and on-line, and via global channel sales through a network of brand and OEM distributors. During that time Penny grew the business into a highly profitable entity through the restructuring of the commercial team and a global license deal with Bayer, the securing of the license and IP of a key women’s health portfolio, and the acquisition of the European manufacturing facility.

  • > Her 12 year tenure at the BBI Group also included several years’ as Group Head of Marketing during which time Penny delivered a global marketing and integration strategy across the group's various entities, through a rapid pre and post-acquisition growth phase. Penny delivered strong financial growth, market impact, and developed skilled teams across OTC and B2B in highly competitive and margin-driven regulated markets.

  • > Prior to joining BBI, Penny began her marketing career as a PR Manager at one of Wales' leading integrated agencies, followed by honing a specialism in FMCG within the licensed confectionery category, with a focus on growth within U.K. multiple grocery retailers. She holds an Honours degree in Journalism from Cardiff University.

Adam Reynolds

Non Executive Chairman

  • > Former stockbroker with over 35 years’ experience within the UK financial services sector
  • > Founded Hansard Group Plc which was admitted to trading on AIM in 2000
  • > Currently a director of several AIM traded companies - non-executive director of EKF Diagnostics Holdings Plc, Optibiotix Plc and Premaitha Health Plc
  • > Director of a number of private companies

Maddy Kennedy

Chief Financial Officer

  • > An experienced CFO in both public and private companies, largely in life science and technology sectors, particularly in growth SME businesses.

  • > She was interim CFO for Ieso Digital Health and Psioxus Therapeutics, in both cases supporting the management team through their next stage of growth. Prior to that she was CFO for Lab21, through its restructure and refinancing and was Finance Director at Alliance Pharma plc from start-up through to the IPO on AIM.

  • > She is an FCCA and has a Post Graduate Diploma in Financial Strategy from Said Business School, Oxford.

Peter Dines

Non-executive Director

  • > COO and Head of Life Sciences at Mercia Asset Management PLC and has particular expertise in commercialising and scaling medtech companies.
  • > Previously MD of obstetric and orthopaedic medical device company Surgicraft before founding and ultimately successfully exiting spinal and orthopaedic implant supplier Surgi C Group.

Neil Mesher

Non-executive Director

  • > Neil has more than 25 years of global experience within the healthcare and consumer electronics industries. He is currently CEO of Philips for the UK and Ireland and is on the Board of the Association of British Healthcare Industries (ABHI), from which he led the industry’s response to the NHS’s “5 Year Forward View”, assessing opportunities for greater integration between industry and the healthcare system. Neil is also a member of the Governments Life Science Industrial Strategy Board, representing the interests of the medical technology sector with other senior leaders from across healthcare.

Lyn Rees

Non-executive Director

  • > Lyn is a seasoned executive in global healthcare and IVD markets. Prior to joining Yourgene Health, formerly Premaitha Health, Lyn was Group CEO at British Biocell International (now BBI Group) for over 9 years.
  • > He began that role at BBI Group following the acquisition of BBI Holdings by Alere in 2008 and in his time, he oversaw the doubling of revenue growth and has developed an accountable and highly effective senior management team with clear focus on innovation, commercial delivery, compliance and operational efficiency. Lyn has completed 7 acquisitions during his tenure at BBI Group, all of which have been successfully integrated. He founded BBI Detection and BBI Animal Health and has demonstrated a strong track record of organic and acquisitive growth.
  • > Before this role, he spent several years as the Managing Director and founder of BBI Healthcare in 2006 following the successful purchase of the GlucoGel product. He first began his business career as the European Marketing Manager at Shimano Europe BV. Lyn holds a degree in Business Studies from the University of Wales.